期刊文献+

肿瘤浸润淋巴细胞免疫组织化学研究 被引量:1

STUDY ON TUMOR INFILTHATING LYMPHOCYTES BY IMMUNOHISTOCHEMICAL TECHNIQUE
下载PDF
导出
摘要 应用免疫组织化学PAP法,对26例常见恶性肿瘤冰冻组织切片中肿瘤浸润淋巴细胞(TIL)进行了原位分析,以了解TIL的组成及分布等原位特征。结果显示:(1)TIL中主要为CD_3^+细胞,其中CD_4^+<CD_8^+,癌实质区CD^4_+/CD_8^+比值小于癌间质区。癌实质区和间质区均含有一定数量CD_2^+5和HLA-DR^+细胞。(2)TIL在瘤组织中一般主要分布于癌间质区,而癌实质区极少,但肾细胞癌TIL呈弥散性分布。研究提示TIL原位组成以T细胞为主,但其中CD_4^+和CD_8^+细胞比例失衡。TIL在瘤组织中分布具一定规律性,但肾细胞癌TIL分布具特殊性。 Employing immunohistochemical technique (PAP method), we studied the expressions of CD3, CD4, CD8, CD25 arid HLA - DR antigens on tumor infiltrating lymphocytes (TIL) and the distribution of TIL from 26 different malignant tumor patients in situ. The results showed that: (1) The most of TIL was CD4+ cell and CD4+ cells were much less than CD8+ ones. The CD4+/CD8+ ratio in tumor interstitium was much higher than that in parenchyma . There were TILs bearing CD25 or HLA - DR antigens in both parenchyma and interstitium in tumor tissue. (2) Lymphocytes infiltating into tumor were mainly located in interstitium and rarely in parenchyma in most tumors, but ’ TILs in renal cell carcinoma (RCC) were distributed scatteredly in tumor tissues just as in interstitium in other tumors due to RCC s lack of typical cancer nest. Through our study we can conclude that: Most TILs are T lympho cytes, and the cell formation of TIL in all tumors are similar to each other; The distribution of TILs in most tumors follow the same rule, but TIL in RCC is an exception.
出处 《神经药理学报》 1998年第A04期13-14,17,共3页 Acta Neuropharmacologica
关键词 肿瘤浸润淋巴细胞 免疫组织化学 Tumor infiltrating lymphocyte Imtnunohistochemistry
  • 相关文献

参考文献4

二级参考文献5

共引文献5

同被引文献24

  • 1袁玫.肿瘤的主动特异性免疫治疗研究进展[J].中国肿瘤生物治疗杂志,1995,2(1):56-60. 被引量:4
  • 2邢承忠,张文范,王舒宝,袁媛,董明.胃癌间质T细胞及其亚群和B细胞的免疫组化研究[J].实用肿瘤学杂志,1995,9(3):3-4. 被引量:3
  • 3Merogi A J, Marrogi A J, Ramesh R, et al. Tumor- host interaction - analysis of cytokines, growthfactors and tumor - infiltrating lymphocytes in ovarian carcinomas [ J ]. Hum Pathol, 1997,28 (3) :321 - 327.
  • 4Pockaj BA, Sherzy RM. Wei JP, et al. Localization of indium labeled TIL to tumor in eatientereceiving adoptive immunotherapy: augmentation with cycloprosohamde and correlation with response [ J ]. Cancer, 1994,73:1731 - 1738.
  • 5Nash MA , Platsoucas CD, Wang BY, et al. Transduction of r IL - 2 expanded CD3 + CD8 + ovarian TIL - derived T cell lines with the GIN a (neor) retroviral vector[J]. Hum Gene Ther, 1995, 6 : 1379 - 1387.
  • 6Itoh Y, Koshita Y, Takahshi M , et at. Characterization of tumor necrosis factor gene transduced tumor infiltration lymphocytes from ascites fluid of cancer patients; analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production [ J ]. Cancer Immunol Immuno Ther, 1995, 40:95-99.
  • 7Raiph SF, Barbara T, Stacie T, et al. Large - scale expansion in interleukin - 2 of tumor infiltration lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy [J]. Immunol Methods, 1994, 167:145-152.
  • 8Freedman RS, P latsoucas CD. Immumo therapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes [ J ]. Cancer T reat Res, 1996, 82 : 115 - 119.
  • 9Dudley ME, Wundedich JR, Yang JC, et al. Adoptive cell transfer therapy following non - myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma [ J ]. Clin Oncol, 2005, 23:2346 - 2357.
  • 10Axdorph U, Porwit M A, Sjoberg J, et al. T - cell - rich B- cell lymphoma- diagnostic and therapeutic aspects [J]. APMIS, 2002, 110(5):379 -390.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部